SCOPUS 정보 검색 플랫폼

Volumn 89, Issue 8, 2000, Pages 1699-1705

A north central cancer treatment group phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma

(8) Pitot, Henry C a Knost, James A b Mahoney, Michelle R a Kugler, John b Krook, James E c Hatfield, Alan K d Sargent, Daniel J a Goldberg, Richard M a

a MAYO CLINIC (United States)

b Illinois Oncology Research Association Community Clinical Oncology Program (CCOP) (United States)

c Duluth Community Clinical Oncology Program (United States)

d Carle Cancer Center (United States)

Author keywords

9 aminocamptothecin; Colorectal carcinoma; Metastatic; Phase II

Indexed keywords

9 AMINOCAMPTOTHECIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CLINICAL TRIAL; COLORECTAL CARCINOMA; DIARRHEA; FEMALE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMAN; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGE; NEOPLASM METASTASIS; NEOPLASM STAGING; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0034667850 PISSN: 0008543X EISSN: None Source Type: Journal
DOI: 10.1002/1097-0142(20001015)89:8<1699::AID-CNCR8>3.0.CO;2-T Document Type: Article

Times cited : (17)

References (27)

1
- 0033006836
- Cancer Statistics, 1999
- (1999) CA Cancer J Clin , vol.49 , pp. 8-31
- Landis, S.H.¹ Murray, T.² Bolden, S.³ Wingo, P.A.⁴

2
- 0033008968
- Global cancer statistics
- (1999) CA Cancer J Clin , vol.49 , pp. 33-64
- Parkin, M.D.¹ Pisani, P.² Ferlay, J.³

3
- 0028956045
- Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report
- (1995) Ann Intern Med , vol.122 , pp. 321-326
- Moertel, C.G.¹ Fleming, T.R.² Macdonald, J.S.³ Haller, D.G.⁴ Laurie, J.A.⁵ Tangen, C.M.⁶

4
- 0028136295
- Improving adjuvant therapy for rectal cancer by combining protracted-infusion 5-FU with radiation therapy after curative surgery
- (1995) N Engl J Med , vol.331 , pp. 502-507
- O'Connell, M.J.¹ Martenson, J.A.² Wieand, H.S.³ Krook, J.E.⁴ Macdonald, J.S.⁵ Haller, D.G.⁶

5
- 0031022988
- Controlled trial of fluorouracil and low-dose leucovorin given for six months as postoperative therapy for colon cancer
- (1997) J Clin Oncol , vol.15 , pp. 246-250
- O'Connell, M.J.¹ Mailliard, J.A.² Kahn, M.J.³ Macdonald, J.S.⁴ Haller, D.G.⁵ Mayer, R.J.⁶

6
- 0032125444
- Surgery for recurrent colon cancer: Strategies for identifying resectable recurrence and success rates after resection
- (1998) Ann Intern Med , vol.129 , pp. 27-35
- Goldberg, R.M.¹ Fleming, T.R.² Tangen, C.M.³ Moertel, C.G.⁴ Macdonald, J.S.⁵ Haller, D.G.⁶

7
- 0028351657
- Chemotherapy of colorectal cancer
- (1994) N Engl J Med , vol.330 , pp. 436-442
- Moertel, C.G.¹

8
- 0024347268
- Biochemical modulation of fluorouracil: Evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma
- (1989) J Clin Oncol , vol.7 , pp. 1407-1417
- Poon, M.A.¹ O'Connell, M.J.² Moertel, C.G.³ Wieand, H.S.⁴ Cullinan, S.A.⁵ Everson, L.K.⁶

9
- 0023924786
- Identification of mammalian topoisomerase I as an intracellular target of the anticancer drug camptothecin
- (1988) Cancer Res , vol.48 , pp. 1722-1726
- Hsiang, Y.-H.¹ Liu, L.F.²

10
- 0024356003
- DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues
- (1989) Cancer Res , vol.49 , pp. 4385-4389
- Hsiang, Y.-H.¹ Liu, L.F.² Wall, M.E.³ Wani, M.C.⁴ Nicholas, A.W.⁵ Manikumar, G.⁶

11
- 7144248725
- Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata
- (1966) J Am Chem Soc , vol.88 , pp. 3888-3890
- Wall, M.E.¹ Wani, M.C.² Cook, C.E.³ Palmer, K.H.⁴ McPhail, A.T.⁵ Sim, G.A.⁶

12
- 0015291595
- Phase II study of camptothecin (NSC 100880) in the treatment of advanced gastrointestinal cancer
- (1972) Cancer Chemother Rep , vol.56 , pp. 95-101
- Moertel, C.G.¹ Schutt, A.J.² Reitmeier, R.J.³ Hahn, R.G.⁴

13
- 0029966672
- Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer
- (1996) J Clin Oncol , vol.14 , pp. 1128-1135
- Rothenberg, M.L.¹ Eckhardt, J.R.² Kuhn, J.G.³ Burris, H.A.⁴ Nelson, J.⁵ Hilsenbeck, S.G.⁶

14
- 0031014627
- Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy
- (1997) J Clin Oncol , vol.15 , pp. 251-260
- Rougier, P.¹ Bugat, R.² Douillard, J.Y.³ Culine, S.⁴ Suc, E.⁵ Brunet, P.⁶

15
- 0030818926
- Phase II trial of irinotecan in patients with metastatic colorectal carcinoma
- (1997) J Clin Oncol , vol.15 , pp. 2910-2919
- Pitot, H.C.¹ Wender, D.B.² O'Connell, M.J.³ Schroeder, G.⁴ Goldberg, R.M.⁵ Rubin, J.⁶

16
- 0024358188
- DNA topoisomerase I - Targeted chemotherapy of human colon cancer in xenografts
- (1989) Science , vol.246 , pp. 1046-1048
- Giovanella, B.C.¹ Stehlin, J.S.² Wall, M.E.³ Wani, M.C.⁴ Nicholas, A.W.⁵ Liu, L.F.⁶

17
- 0026694680
- Complete inhibition of growth followed by death of human malignant melanoma cells in vitro and regression of human melanoma xenografts in immunodeficient mice induced by camptothecins
- (1992) Cancer Res , vol.52 , pp. 3980-3987
- Pantazis, P.¹ Hinz, H.R.² Mendoza, J.T.³ Kozielski, A.J.⁴ Williams, L.J.⁵ Stehlin, J.S.⁶

18
- 0025912553
- Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin
- (1991) Cancer Res , vol.51 , pp. 3052-3055
- Giovanella, B.P.¹ Hinz, H.R.² Kozielski, A.J.³ Stehlin, J.S.⁴ Silber, R.⁵ Potmesil, M.⁶

19
- 9244231199
- Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients
- (1996) J Clin Oncol , vol.14 , pp. 1236-1244
- Dahut, W.¹ Harold, N.² Takimoto, C.³ Allegra, C.⁴ Chen, A.⁵ Hamilton, J.M.⁶

20
- 0030905494
- Phase I trial of a prolonged infusion of 9-AC in adult patients with solid tumors
- (1997) J Clin Oncol , vol.15 , pp. 1492-1501
- Takimoto, C.H.¹ Dahut, W.² Marino, M.T.³ Nakashima, H.⁴ Liang, M.D.⁵ Harold, N.⁶

21
- 0023176979
- Confidence intervals for a binominal parameter based on multistage tests
- (1987) Biometrics , vol.43 , pp. 81-93
- Duffy, D.E.¹ Santner, T.J.²

22
- 33845382806
- Nonparametric estimation from incomplete observation
- (1958) J Am Stat Assoc , vol.53 , pp. 457-481
- Kaplan, E.¹ Meier, P.²

23
- 0000336139
- Regression models and life tables (with discussion)
- (1972) JR Stat Soc (B) , vol.34 , pp. 187-220
- Cox, D.R.¹

24
- 0001874763
- A phase I study of 9-amino-camptothecin (9-AC) by prolonged infusion to 21 days
- (1996) Ann Oncol , Issue.1 SUPPL. , pp. 130
- Hochster, H.¹ Potmesil, M.² Liebes, J.³ Sorich, J.⁴ Taubes, B.⁵ Dewey, D.⁶

25
- 0030856927
- Phase II trial of 9-aminocamptothecin administered as a 72-hour continuous infusion in metastatic colorectal carcinoma
- (1997) J Clin Oncol , vol.5 , pp. 2905-2909
- Pazdur, R.¹ Diaz-Canton, E.² Ballard, W.P.³ Bradof, J.E.⁴ Graham, S.⁵ Arbuck, S.G.⁶

26
- 0030667871
- 9-aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma
- (1997) Cancer , vol.80 , pp. 1727-1732
- Saltz, L.B.¹ Kemeny, N.E.² Tong, W.³ Harrison, J.⁴ Berkery, R.⁵ Kelsen, D.P.⁶

27
- 0031935226
- Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeks
- (1998) J Clin Oncol , vol.16 , pp. 1122-1130
- Siu, L.L.¹ Oza, A.M.² Eisenhauer, E.A.³ Firby, P.S.⁴ Thiessen, J.J.⁵ Michael, M.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.